Highlights CRMH and CityU Jointly Develop New Drug for “Amblyopia” Treatment, Administers First Dose in Clinical Trial admin September 11, 2025
Highlights CRMH and CityU Pioneer Neu-001 for Amblyopia Treatment Secures FDA Approval for Clinical Trials admin December 17, 2024
Highlights A delegation led by Lu Fangjun, Deputy Director of the Bureau of science communication, Chinese Academy of sciences, Wang Yifang, Academician of Chinese Academy of Sciences and Director of the Institute of High Energy Physics, Chinese Academy of Sciences, and Zhao Zhentang, Academician of the Chinese Academy of Engineering and Director of the Shanghai Synchrotron Radiation Facility, visited the research center for investigation and research. admin July 25, 2024
